
Organic Process Research and Development p. 1405 - 1419 (2020)
Update date:2022-08-15
Topics:
Baenziger, Markus
Baierl, Marcel
Devanathan, Krishnaswamy
Eswaran, Sumesh
Fu, Peng
Gschwend, Bjoern
Haller, Michael
Kasinathan, Gopu
Kovacic, Nikola
Langlois, Audrey
Li, Yongfeng
Schuerch, Friedrich
Shen, Xiaodong
Wan, Yinbo
Wickendick, Regina
Xie, Siwei
Zhang, Kai
The development of the synthetic process to the selective estrogen receptor degrader (SERD) drug candidate LSZ102 from the medicinal chemistry synthesis to the streamlined large-scale manufacturing route is described. The synthesis of LSZ102 could be sign
View More
Shanghai Gsyn Chemical Co.,Ltd.
Contact:86-021-67158290
Address:86-021-67158291
Wuxi Forest Biological Co.,Ltd
Contact:+86-510-81602300
Address:Room 317,Building D, No.159 middle Chengjiang Road,Jiangyin Wuxi city.
Shijiazhuang City Xiehe Pharmaceutical Co., Ltd
Contact:+86-311-80817929
Address:Shangzhuang,Shijiazhuang,China
Xi'an yuanfar international trade company
website:https://www.yuanfarchemical.com
Contact:86-029-88745613 ext 828
Address:Floor19th ,B Building, Oak Block,No.36 South Fenghui Road, Dev. Zone of High-Tech Ind.,Xi’an, China
Contact:+86-28-88523492
Address:714rooms of Time Square, Pujiang County
Doi:10.1002/ejoc.201400004
(2014)Doi:10.1021/jo00097a023
(1994)Doi:10.14233/ajchem.2014.15611
(2014)Doi:10.1021/np980142v
(1999)Doi:10.1021/jm00007a001
(1995)Doi:10.3987/COM-14-12954
(2014)